Report of the TFOS/ARVO symposium on global treatments for dry eye disease: An unmet need

Sullivan D.A., Hammitt K.M., Schaumberg D.A., Sullivan B.D., Begley C.G., Gjorstrup P., Garrigue J.-S., Nakamura M., Quentric Y., Barabino S., Dalton M., Novack G.D.

2012
Ocular Surface

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Post-Approval studies/RWE

Affiliations

Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, 20 Staniford Street, Boston, 02114, MA, United States; Sjögren's Syndrome Foundation, Bethesda, MD, United States; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; TearLab Corporation, San Diego, CA, United States; School of Optometry, Indiana University, Bloomington, IN, United States; Resolvyx Pharmaceuticals, Bedford, MA, United States; Novagali Pharma, Evry, France; Santen Pharmaceutical Co., Nara, Japan; Iris Pharma, La Gaude, France; Clinica Oculistica, Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa, Italy; Dalton and Associates, Reading, PA, United States; PharmadLogic, San Rafael, CA, United States

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P, Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

View all Front of the eye (FOTE) publications